| |
| |
|
| Insider
Information: |
Wallace Owen B. |
| Relationship: |
Chief Scientific Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
133,438 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
133,438 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fulcrum Therapeutics, Inc. |
FULC |
Chief Scientific Officer |
2020-09-14 |
133,438 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FULC |
Fulcrum Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2020-09-14 |
4 |
OE |
$7.84 |
$49,784 |
D/D |
6,350 |
133,438 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2020-07-08 |
4 |
AS |
$20.00 |
$59,020 |
D/D |
(2,951) |
127,088 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2020-07-08 |
4 |
OE |
$7.84 |
$23,136 |
D/D |
2,951 |
130,039 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2020-06-30 |
4 |
AS |
$20.00 |
$2,820 |
D/D |
(141) |
127,088 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2020-06-30 |
4 |
OE |
$7.84 |
$1,105 |
D/D |
141 |
127,229 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2020-05-28 |
4 |
AS |
$20.00 |
$44,640 |
D/D |
(2,232) |
127,088 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2020-05-28 |
4 |
OE |
$7.84 |
$17,499 |
D/D |
2,232 |
129,320 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2020-05-27 |
4 |
AS |
$20.00 |
$8,960 |
D/D |
(448) |
127,088 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2020-05-27 |
4 |
OE |
$7.84 |
$3,512 |
D/D |
448 |
127,536 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2020-05-26 |
4 |
AS |
$20.00 |
$8,240 |
D/D |
(412) |
127,088 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2020-05-26 |
4 |
OE |
$7.84 |
$3,230 |
D/D |
412 |
127,500 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2020-02-19 |
4 |
AS |
$20.00 |
$121,760 |
D/D |
(6,088) |
127,088 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Chief Scientific Officer |
• – – |
2020-02-19 |
4 |
OE |
$7.84 |
$47,730 |
D/D |
6,088 |
133,176 |
0 |
- |
|
| FULC |
Fulcrum Therapeutics, Inc... |
Chief Scientific OfficerOffice |
• – – |
2019-07-17 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
127,088 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
